Scientific evidence for NanoEcho’s imaging method
An image of magnetic nanoparticles in human tissue generated by magnetomotive ultrasound is shown for the first time. The image created with NanoEcho’s prototype system in the ongoing investigator-led study at Sahlgrenska University Hospital has now been published in a peer-reviewed article (1). Treatment of rectal cancer patients is largely based on how far the […]
Board member resigns at his own request due to medical reasons
At his own request, BG (Bengt-Göran) Svensson has chosen to leave NanoEcho’s board for medical reasons. At the same time, he announces that he is leaving all of his board assignments. BG Svensson has been an elected board member on NanoEcho’s board since 2020. “This was sad news, I have appreciated working together with BG […]
NanoEcho announces collaboration partner for the nanoparticle
NanoEcho and SPL medical have signed a Letter of Intent and initiated a cooperation on regulatory partnership and supply for the iron-oxide based nanoparticle. The aim of the collaboration is to achieve market approval for the NanoEcho indication, diagnostics of rectal cancer lymph node metastases. NanoEcho and SPL medical have signed a Letter of Intent […]
Go ahead to start clinical development study at Skåne University Hospital in Malmö
NanoEcho has been cleared to start a clinical development study at Skåne University Hospital in Malmö. The ethics committee has already approved the study and recruitment of patients is planned to commence during the fall. NanoEcho develops a method intended to facilitate differentiation between healthy and diseased tissue and at the same time determine the […]
NanoEcho and us4us have signed a letter of intent
NanoEcho has chosen the supplier us4us and started collaboration around the development and future manufacturing of the imaging device. NanoEcho and us4us have signed a letter of intent and agreed to collaborate regarding the development of NanoEcho’s imaging device, specifically the ultrasound scanner unit. The imaging device is aimed to be used at medical hospitals, as support […]
A new Board has been appointed at NanoEcho – increased focus on commercialization
A new Board that reflects the Company’s development has been appointed. The newly appointed Chairman is Daniel Johnsson, former CEO and founder of, among others, Exertis Nordics, now investor and advisor. A new member of the Company’s Board is PhD and Business Coach Ann-Christin Malmborg Hager. At the Annual General Meeting, NanoEcho elected Daniel Johnsson […]
NanoEcho takes the next step and enters a detailed product development phase
NanoEcho has conducted a “Design Input Review” – a systematic review of collected requirements and development plans for the product development phase. The company now enters a detailed design development phase with the objective of developing a prototype prepared for commercialization. The result of the conducted review is that all requirements; clinical, regulatory, technical and […]
NanoEcho has chosen supplier of ultrasound transducer
NanoEcho has chosen the supplier Vermon SA, and started cooperation for the development and future manufacturing of the ultrasound transducer. As an important step in NanoEchos work, to design and produce a product for commercial use, NanoEcho will collaborate with Vermon in the development of the ultrasound transducer. NanoEcho and Vermon have signed a Letter […]
